Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: Baseline predictors and associated clinical outcomes

Heart Rhythm

Volumn 11, Issue 11, 2014, Pages 1991-1998

  Friedman, Daniel J ^a   Upadhyay, Gaurav A ^b   Rajabali, Alefiyah ^b   Altman, Robert K ^c   Orencole, Mary ^b   Parks, Kimberly A ^b   Moore, Stephanie A ^b   Park, Mi Young ^d   Picard, Michael H ^b   Ruskin, Jeremy N ^b   Singh, Jagmeet P ^b   Heist, E Kevin ^b  

^a DUKE UNIVERSITY HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d Hallym University   (South Korea)

Author keywords

Biventricular pacing; Cardiac resynchronization therapy; Cardiomyopathy; Heart failure; Remodeling; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEXILETINE; SOTALOL;

AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE THERAPY; DISEASE ASSOCIATION; DIURETIC THERAPY; DRUG USE; ECHOCARDIOGRAPHY; EVALUATION STUDY; FEMALE; FOLLOW UP; HEART VALVE SURGERY; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PACEMAKER IMPLANTATION; PATIENT HISTORY OF SURGERY; PRIORITY JOURNAL; PROGRESSIVE VENTRICULAR DYSFUNCTION; QRS INTERVAL; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT RESPONSE; TRICUSPID VALVE REGURGITATION; BIOASSAY; DISEASE COURSE; ECHOGRAPHY; HEART MUSCLE ISCHEMIA; MORTALITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; VENTRICULAR FIBRILLATION;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; VENTRICULAR FIBRILLATION;

EID: 84938682534     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.08.005     Document Type: Article

References (17)

1. Moss, A.J., Hall, W.J., Cannom, D.S., et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361 (2009), 1329–1338.
2. Abraham, W.T., Fisher, W.G., Smith, A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002), 1845–1853.
3. Bristow, M.R., Saxon, L.A., Boehmer, J., Krueger, S., Kass, D.A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B.G., DeVries, D.W., Feldman, A.M., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004), 2140–2150.
4. Cleland, J.G., Daubert, J.C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L., Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27 (2006), 1928–1932.
5. Tang, A.S., Wells, G.A., Talajic, M., et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363 (2010), 2385–2395.
6. Solomon, S.D., Foster, E., Bourgoun, M., Shah, A., Viloria, E., Brown, M.W., Hall, W.J., Pfeffer, M.A., Moss, A.J., Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy. Circulation 122 (2010), 985–992.
7. Soliman, O.I., Geleijnse, M.L., Theuns, D.A., Nemes, A., Vletter, W.B., van Dalen, B.M., Motawea, A.K., Jordaens, L.J., ten Cate, F.J., Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy. Am J Cardiol 101 (2008), 651–657.
8. Yu, C.M., Bleeker, G.B., Fung, J.W., Schalij, M.J., Zhang, Q., van der Wall, E.E., Chan, Y.S., Kong, S.L., Bax, J.J., Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112 (2005), 1580–1586.
9. Gold, M.R., Linde, C., Abraham, W.T., Gardiwal, A., Daubert, J.C., The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm 8 (2011), 679–684.
10. Di Biase, L., Gasparini, M., Lunati, M., et al. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol 52 (2008), 1442–1449.
11. Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S, Foster E, Huang DT, Klein HU, Zareba W, Eldar M, Goldenberg I. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;57:2416–2423.
12. Altman, R.K., Parks, K.A., Schlett, C.L., et al. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J 33 (2012), 2181–2188.
13. Mullens, W., Grimm, R.A., Verga, T., Dresing, T., Starling, R.C., Wilkoff, B.L., Tang, W.H., Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 53 (2009), 765–773.
14. Bose, A., Upadhyay, G.A., Kandala, J., Heist, E.K., Mela, T., Parks, K.A., Singh, J.P., Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy?. J Cardiovasc Electrophysiol, 2014 In Press.
15. Auger, D., Bleeker, G.B., Bertini, M., Ewe, S.H., van Bommel, R.J., Witkowski, T.G., Ng, A.C., van Erven, L., Schalij, M.J., Bax, J.J., Delgado, V., Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony. Eur Heart J 33 (2012), 913–920.
16. Rickard, J., Jackson, G., Spragg, D.D., Cronin, E.M., Baranowski, B., Tang, W.H., Wilkoff, B.L., Varma, N., QRS prolongation induced by cardiac resynchronization therapy correlates with deterioration in left ventricular function. Heart Rhythm 9 (2012), 1674–1678.
17. Sanderson, J.E., Yu, C.M., Can cardiac resynchronization therapy cause harm?. Eur Heart J 33 (2012), 816–818.